Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137215 · ClinicalTrials.gov registry record · NA
Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites
A NA study, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00137215: Completed NA study, sponsored by United States Army Institute of Surgical Research.
NCT00137215 is a NA study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137215, a NA study, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to compare one type of dressing against the current standard dressing that is used to cover an unburned area of the skin where a piece of skin is removed to cover another part of the body that was burned. Hypothesis: The mean healing time for wounds treated with the Silverlon Dressing will be less than the mean healing time for wounds treated with Xeroform Dressing.
Interventions
- DEVICE Silverlon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00137215 record still lists
NCT00137215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Silverlon is the first listed.
NCT00137215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00137215 about?
NCT00137215 is a clinical study titled "Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites". The purpose of this study is to compare one type of dressing against the current standard dressing that is used to cover an unburned area of the skin where a piece of skin is removed to cover another part of the body that was burned. Hypothesis: The mean healing time for wounds treated with the Sil...
What is the current status of trial NCT00137215?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2006-01. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00137215?
The interventions under investigation include: Silverlon (DEVICE).
Who is sponsoring clinical trial NCT00137215?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00137215's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia